Home
/
Clinical Trial
/
Omalizumab to Treat Hyper-IgE...

Omalizumab to Treat Hyper-IgE (Job’s) Syndrome

May 27, 2020checkorphan

Learn more about:

Hyper-IgE Syndrome

Related Access Program

M. Scott Perry – Epileptic Encephalopathies Associated With SCN1A Mutations

Related Clinical Trial

Beneficial Effect of Intravenous Magnesium Sulphate in Term Neonates With Hypoxic Ischemic Encephalopathy(HIE) Omalizumab to Treat Hyper-IgE (Job’s) Syndrome

Recruitment Information

Administrative Informations